Serum calprotectin is increased in early axial spondyloarthritis with sacroiliitis and objective signs of inflammation: Results from the DESIR cohort

Joint Bone Spine. 2021 Jan;88(1):105068. doi: 10.1016/j.jbspin.2020.08.003. Epub 2020 Sep 5.

¹ Department of Rheumatology, CHU Grenoble Alpes, Echirolles, France; University Grenoble Alpes, GREPI TIMC, CNRS UMR 5525, Grenoble, France. Electronic address: xromand@chu-grenoble.fr.
² University Grenoble Alpes, GREPI TIMC, CNRS UMR 5525, Grenoble, France; Department of Biology, CHU Grenoble Alpes, La Tronche, France.
³ Sinnovial, Grenoble, France.
⁴ University Grenoble Alpes, GREPI TIMC, CNRS UMR 5525, Grenoble, France; Sinnovial, Grenoble, France.
⁵ Department of Rheumatology, University Teaching Hospital (CHRU), EA4266, Université Bourgogne Franche-Comté, Besançon, France.
⁶ Department of Rheumatology, Sorbonne Université, INSERM CRSA, AP-HP Saint-Antoine Hospital, Paris, France.
⁷ Department of Rheumatology, CHU Grenoble Alpes, Echirolles, France; University Grenoble Alpes, GREPI TIMC, CNRS UMR 5525, Grenoble, France.

No abstract available

Keywords: Biomarker; Calprotectin; S100 proteins; Spondyloarthritis; Structural damage.

Publication types